Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 55 years of age or older
- People who have had at least one episode of bleeding after menopause
- People who have had an endometrial biopsy (a small tissue sample taken from the lining of the womb) performed at Mayo Clinic (Minnesota, Arizona, or Florida), a Mayo Clinic Health System location, or another external medical institution
- People who have agreed to take part in the study
Who may not be able to join:
- People whose diagnostic tests were carried out more than 90 days apart from each other
- People who are unable to have a transvaginal ultrasound (an internal scan of the womb area using a small device inserted into the vagina) due to a physical reason, or who do not wish to have this procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gretchen E Glaser, MD, Mayo Clinic in Rochester
Phone: 855-776-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Accuracy of artificial intelligence (AI) algorithm applied to transvaginal ultrasound (TVUS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.